PMParul Mishra

Parul Mishra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Parul Mishra has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Residue-specific dominant-negative mutant of ubiquitin reveals functional selectivity as Ubp14 deubiquitinase inhibitor

    by Amrita Arpita Padhy, Saanya Yadav, Subhashree Sahoo, Kummari Shivani, Lahari Reddy Balireddygari, Himanshu Joshi, Parul Mishra

    Multifunctional proteins encode specificity through nuanced molecular interactions that operate in the presence of abundant wild-type molecules. Previous studies on multifunctional proteins have shown how certain regulated interactions parse complex biological activities into discrete functional modules. Discrete interaction edges can function as regulatory nodes whose perturbations selectively remodel proteostasis output, especially under disease conditions. However, whether such interaction specificity can be harnessed to selectively manipulate functional modules and reveal residue-level control principles, remains largely unexplored. Here, we screened for dominant negative mutations that impact partner-selective functions linked to Leu8, a critical binding residue on ubiquitin. Our results reveal that the Leu8Ala mutation specifically leads to accumulation of polyubiquitinated proteins and decreased levels of free ubiquitin suggesting loss of deubiquitinase function in yeast cells. Cellular and biochemical analyses establish that the Leu8Ala variant of ubiquitin specifically inhibits the yeast deubiquitinase, Ubp14, and its human homolog, USP5. We further demonstrate remodelling of the binding interface with increased interface contacts for the variant and Ubp14 complex. The variant shows a higher inhibitory potency compared to the wild-type ubiquitin and can inhibit Ubp14 both as unconjugated and as conjugated ubiquitin chain indicating the strength of its inhibitory function. Our results provide mechanistic insight into how edge perturbations in ubiquitin can reveal critical nodes that impact selective functions and thus fine-tune the cellular proteostasis network for therapeutic benefit.

  • Open Access

    The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis

    by Gopu Sandeep, Srijoni Pahari, Vinayak Nayak, Rohit Gundamaraju, Parul Mishra, Ashish Misra

    Prostate cancer remains one of the most common malignancies in men, with its progression strongly influenced by androgen signaling. While genetic alterations are well-documented in prostate cancer, growing evidence highlights the contribution of environmental factors, particularly diet and the gut microbiome, in modulating disease risk and therapy response. The gut microbiota plays a crucial role in regulating host metabolism, immune responses, and hormone activity. Recent findings suggest that specific microbial communities influence androgen biosynthesis and metabolism through enzymes such as β-glucuronidase, altering systemic androgen availability and imp acting tumor progression. Additionally, microbial metabolites, including short-chain fatty acids, secondary bile acids, and bacterial genotoxins, can affect inflammatory pathways and cellular signaling relevant to prostate tumorigenesis. Experimental studies also indicate that modifying the gut microbiota through dietary interventions, probiotics, or fecal microbiota transplantation can influence tumor growth and improve responses to immunotherapy and hormone-based treatments. In this review we present the current knowledge on gut–prostate axis, examine the mechanistic links between microbial activity and prostate cancer biology, and discuss emerging microbiome-based strategies as potential therapies. A deeper understanding of this bidirectional crosstalk could pave the way for microbiome-informed approaches to prevention, diagnosis, and personalized treatment of prostate cancer


  • Open Access

    Ubiquitin signatures on aggregating proteins in neurodegeneration

    by Subhashree Sahoo, Amrita Arpita Padhy, Kummari Shivani, Ashish Misra, Parul Mishra

    The aberrant accumulation of misfolded proteins marked by cellular dysfunction and progressive neuronal loss is the hallmark of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis. This review examines the pivotal role of ubiquitin modifications in altering the fate of aggregation-prone proteins such as tau, α-synuclein, mutant huntingtin, TAR DNA-binding protein 43 and superoxide dismutase 1. The ubiquitin signatures identified by their linkage types, chain architectures and site specificities emerge as a complex regulatory language that influences the clearance, aggregation or cellular propagation of these aggregating proteins. The dysregulation of other components of the ubiquitin association pathways, such as impaired E3 ligases and deubiquitinases, also contributes to the inefficient protein disposal and disease progression. Understanding how ubiquitin signatures alter the spatiotemporal dynamics of aggregating proteins is critical for advancing our knowledge of disease biology. Here, we focus on the role of ubiquitin modifications and their associated regulators affecting protein fate and neurotoxicity, and highlight the current therapeutic strategies targeting the degradation of aggregating proteins to uncover potential avenues for treating neurodegenerative diseases.


  • AR-V7 expression facilitates accelerated G2/M phase transition in castration-resistant prostate cancer

    by Taruna Saini, Parth Gupta, Rajnikant Raut, Vinayak Nayak, Pabbithi Bharathnaveen, Parul Mishra, Ashish Misra


  • Open Access

    Systematic profiling of dominant ubiquitin variants reveals key functional nodes contributing to evolutionary selection

    by Amrita Arpita Padhy, David Mavor, Subhashree Sahoo, Daniel N.A. Bolon, Parul Mishra


  • Principles, Methods, and Applications of Protein Folding Inside Cells

    by Subhashree Sahoo, Kummari Shivani, Amrita Arpita Padhy, Varsha Kumari, Parul Mishra


  • Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance

    by Subhashree Sahoo, Amrita Arpita Padhy, Varsha Kumari, Parul Mishra

    Synuclein aggregation in neuronal cells is the primary underlying cause of synucleinopathies. Changes in gene expression patterns, structural modifications, and altered interactions with other cellular proteins often trigger aggregation of α-synuclein, which accumulates as oligomers or fibrils in Lewy bodies. Although fibrillar forms of α-synuclein are primarily considered pathological, recent studies have revealed that even the intermediate states of aggregates are neurotoxic, complicating the development of therapeutic interventions. Autophagy and ubiquitin–proteasome pathways play a significant role in maintaining the soluble levels of α-synuclein inside cells; however, the heterogeneous nature of the aggregates presents a significant bottleneck to its degradation by these cellular pathways. With studies focused on identifying the proteins that modulate synuclein aggregation and clearance, detailed mechanistic insights are emerging about the individual and synergistic effects of these degradation pathways in regulating soluble α-synuclein levels. In this article, we discuss the impact of α-synuclein aggregation on autophagy-lysosome and ubiquitin–proteasome pathways and the therapeutic strategies that target various aspects of synuclein aggregation or degradation via these pathways. Additionally, we also highlight the natural and synthetic compounds that have shown promise in alleviating the cellular damage caused due to synuclein aggregation.


  • Open Access

    A complete allosteric map of a GTPase switch in its native network

    by Christopher J. P. Mathy, Parul Mishra, Julia M. Flynn, Tina Perica, David Mavor, Daniel N. A. Bolon, Tanja Kortemme

    Allosteric regulation is central to protein function in cellular networks 1 . However, despite technological advances 2,3 most studies of allosteric effects on function are conducted in heterologous environments 2,4,5 , limiting the discovery of allosteric mechanisms that rely on endogenous binding partners or posttranslational modifications to modulate activity. Here we report an approach that enables probing of new sites of allosteric regulation at residue-level resolution in essential eukaryotic proteins in their native biological context by comprehensive mutational scanning. We apply our approach to the central GTPase Gsp1/Ran. GTPases are highly regulated molecular switches that control signaling, with switching occurring via catalyzed GTP hydrolysis and nucleotide exchange. We find that 28% of 4,315 assayed mutations in Gsp1/Ran are highly deleterious, showing a toxic response identified by our assay as gain-of-function (GOF). Remarkably, a third of all positions enriched for GOF mutations (20/60) are outside the GTPase active site. Kinetic analysis shows that these distal sites are allosterically coupled to the active site, including a novel cluster of sites that alter the nucleotide preference of Gsp1 from GDP to GTP. We describe multiple distinct mechanisms by which allosteric mutations alter Gsp1/Ran cellular function by modulating GTPase switching. Our systematic discovery of new regulatory sites provides a functional map relevant to other GTPases such as Ras that could be exploited for targeting and reprogramming critical biological processes.


  • Open Access

    Pervasive contingency and entrenchment in a billion years of Hsp90 evolution

    by Tyler N. Starr, Julia M. Flynn, Parul Mishra, Daniel N. A. Bolon, Joseph W. Thornton

    Interactions among mutations within a protein have the potential to make molecular evolution contingent and irreversible, but the extent to which epistasis actually shaped historical evolutionary trajectories is unclear. To address this question, we experimentally measured how the fitness effects of historical sequence substitutions changed during the billion-year evolutionary history of the heat shock protein 90 (Hsp90) ATPase domain beginning from a deep eukaryotic ancestor to modern Saccharomyces cerevisiae. We found a pervasive influence of epistasis. Of 98 derived amino acid states that evolved along this lineage, about half compromise fitness when introduced into the reconstructed ancestral Hsp90. And the vast majority of ancestral states reduce fitness when introduced into the extant S. cerevisiae Hsp90. Overall, more than 75% of historical substitutions were contingent on permissive substitutions that rendered the derived state nondeleterious, became entrenched by subsequent restrictive substitutions that made the ancestral state deleterious, or both. This epistasis was primarily caused by specific interactions among sites rather than a general effect on the protein’s tolerance to mutation. Our results show that epistasis continually opened and closed windows of mutational opportunity over evolutionary timescales, producing histories and biological states that reflect the transient internal constraints imposed by the protein’s fleeting sequence states. Significance When mutations within a protein change each other’s functional effects—a phenomenon called epistasis—the paths available to evolution at any moment in time depend on the specific set of changes that previously occurred in the protein. The extent to which epistasis has shaped historical evolutionary trajectories is unknown. Using a high-precision bulk fitness assay and ancestral protein reconstruction, we measured the fitness effects in ancestral and extant sequences of all historical substitutions that occurred during the billion-year trajectory of an essential protein. We found that most historical substitutions were contingent on prior epistatic substitutions and/or entrenched by subsequent changes. These results establish that epistasis caused widespread, consequential shifts in the site-specific fitness constraints that shaped the protein’s historical trajectory.


  • Open Access

    Systematic Mutant Analyses Elucidate General and Client-Specific Aspects of Hsp90 Function

    by Parul Mishra, Julia M. Flynn, Tyler N. Starr, Daniel N.A. Bolon